Dynamics in the Biopharmaceutical Industry: Next Generation Pharmaceuticals Summit Q2 2011

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

The pharmaceutical and biotechnology industry is in a state of transition. Reorganization, mergers and acquisitions, consolidation, and portfolio changes are being evaluated in order to maintain growth centers in the face of a myriad of serious challenges. Overall, companies are looking to align with areas of growth opportunity as well as new business strategy and product development paradigms.

Table of Contents

Dynamics in the Biopharmaceutical Industry: Next Generation Pharmaceuticals Summit Q2 2011Analysis of the Changing Dynamics in the Biopharmaceutical Industry and 2011 Next Generation Pharmaceuticals SummitMarket Insight




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.